Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT01898312

BRCA1/2 and Effect of Mifepristone on the Breast

Ovarian steroids, as well as their synthetic counterparts gestagens and estrogens have a role in breast cell proliferation and the development of breast cancer.…

Sweden45 participantsStarted 2013-09

Treatment: Mifepristone